Haematology 2018

GHSG HD10 Clinical Trial Weakest vs strongest arm (FFTF)

HD10, arms A v s. D (ITT)

1.0

0.9

0.8

0.7

0.6

0.5

0.4

Arm difference in 5-year-FFTF -1,6% 95% CI [-6,3%; 3,1%]

0.3

0.2

Freedom from Treatment Failure

0.1

A

D

0.0

Freedom from Treatment Failure

0

12

24

36

48

60

72

84

96

108

120

Time [months]

Pts. at Risk

Time (months)

A D

298 299

277 275

264 265

255 252

239 239

217 199

167 151

121 110

74 66

35 28

3 4

Engert A et al; NEJM 2010

Made with FlippingBook - professional solution for displaying marketing and sales documents online